While some countries have made great progress with their COVID-19 vaccine rollouts, there’s still a major stumbling block when it comes to vaccinating the rest of the world. Abigail Bimman looks at the debate over whether COVID-19 vaccine patents should be waived temporarily, which supporters argue will help get more doses made and get more people vaccinated faster.
- New drug price rule could save Canada billions, parliamentary budget officer reports
- Canada lacks ‘political will’ to waive COVID-19 vaccine patents, Bolivian minister says
- Canada again delays overhaul to patented medicine pricing system